A high-affinity human PD-1/PD-L2 complex informs avenues for small-molecule immune checkpoint drug discovery
Abstract
Immune checkpoint blockade of programmed death-1 (PD-1) by monoclonal antibody drugs has delivered breakthroughs in the treatment of cancer. Nonetheless, small-molecule PD-1 inhibitors could lead to increases in treatment efficacy, safety, and global access. While the ligand-binding surface of apo-PD-1 is relatively flat, it harbors a striking pocket in the murine PD-1/PD-L2 structure. An analogous pocket in human PD-1 may serve as a small-molecule drug target, but the structure of the human complex is unknown. Because the CC' and FG loops in murine PD-1 adopt new conformations upon binding PD-L2, we hypothesized that mutations in these two loops could be coupled to pocket formation and alter PD-1’s affinity for PD-L2. Here, we conducted deep mutational scanning in these loops and used yeast surface display to select for enhanced PD-L2 binding. A PD-1 variant with three substitutions binds PD-L2 with an affinity two orders of magnitude higher than that of the wild-type protein, permitting crystallization of the complex. We determined the X-ray crystal structures of the human triple-mutant PD-1/PD-L2 complex and the apo triple-mutant PD-1 variant at 2.0 Å and 1.2 Å resolution, respectively. Binding of PD-L2 is accompanied by formation of a prominent pocket in human PD-1, as well asmore »
- Authors:
-
[1];
[2]
- Stanford Univ., CA (United States); Stanford Univ. School of Medicine, CA (United States)
- Stanford Univ., CA (United States); Stanford Univ. School of Medicine, CA (United States); Chan Zuckerberg Biohub, San Francisco, CA (United States)
- Publication Date:
- Research Org.:
- SLAC National Accelerator Lab., Menlo Park, CA (United States)
- Sponsoring Org.:
- USDOE Office of Science (SC), Basic Energy Sciences (BES)
- OSTI Identifier:
- 1594989
- Grant/Contract Number:
- AC02-76SF00515; DP1 DA043893; P41GM103393
- Resource Type:
- Accepted Manuscript
- Journal Name:
- Proceedings of the National Academy of Sciences of the United States of America
- Additional Journal Information:
- Journal Volume: 116; Journal Issue: 49; Journal ID: ISSN 0027-8424
- Publisher:
- National Academy of Sciences
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 59 BASIC BIOLOGICAL SCIENCES; PD-1; PD-L2; immune checkpoint; drug discovery
Citation Formats
Tang, Shaogeng, and Kim, Peter S. A high-affinity human PD-1/PD-L2 complex informs avenues for small-molecule immune checkpoint drug discovery. United States: N. p., 2019.
Web. doi:10.1073/pnas.1916916116.
Tang, Shaogeng, & Kim, Peter S. A high-affinity human PD-1/PD-L2 complex informs avenues for small-molecule immune checkpoint drug discovery. United States. doi:https://doi.org/10.1073/pnas.1916916116
Tang, Shaogeng, and Kim, Peter S. Thu .
"A high-affinity human PD-1/PD-L2 complex informs avenues for small-molecule immune checkpoint drug discovery". United States. doi:https://doi.org/10.1073/pnas.1916916116. https://www.osti.gov/servlets/purl/1594989.
@article{osti_1594989,
title = {A high-affinity human PD-1/PD-L2 complex informs avenues for small-molecule immune checkpoint drug discovery},
author = {Tang, Shaogeng and Kim, Peter S.},
abstractNote = {Immune checkpoint blockade of programmed death-1 (PD-1) by monoclonal antibody drugs has delivered breakthroughs in the treatment of cancer. Nonetheless, small-molecule PD-1 inhibitors could lead to increases in treatment efficacy, safety, and global access. While the ligand-binding surface of apo-PD-1 is relatively flat, it harbors a striking pocket in the murine PD-1/PD-L2 structure. An analogous pocket in human PD-1 may serve as a small-molecule drug target, but the structure of the human complex is unknown. Because the CC' and FG loops in murine PD-1 adopt new conformations upon binding PD-L2, we hypothesized that mutations in these two loops could be coupled to pocket formation and alter PD-1’s affinity for PD-L2. Here, we conducted deep mutational scanning in these loops and used yeast surface display to select for enhanced PD-L2 binding. A PD-1 variant with three substitutions binds PD-L2 with an affinity two orders of magnitude higher than that of the wild-type protein, permitting crystallization of the complex. We determined the X-ray crystal structures of the human triple-mutant PD-1/PD-L2 complex and the apo triple-mutant PD-1 variant at 2.0 Å and 1.2 Å resolution, respectively. Binding of PD-L2 is accompanied by formation of a prominent pocket in human PD-1, as well as substantial conformational changes in the CC' and FG loops. The structure of the apo triple-mutant PD-1 shows that the CC' loop adopts the ligand-bound conformation, providing support for allostery between the loop and pocket. This human PD-1/PD-L2 structure provide critical insights for the design and discovery of small-molecule PD-1 inhibitors.},
doi = {10.1073/pnas.1916916116},
journal = {Proceedings of the National Academy of Sciences of the United States of America},
number = 49,
volume = 116,
place = {United States},
year = {2019},
month = {11}
}
Free Publicly Available Full Text
Publisher's Version of Record
Other availability
Search WorldCat to find libraries that may hold this journal
Cited by: 4 works
Citation information provided by
Web of Science
Web of Science
Save to My Library
You must Sign In or Create an Account in order to save documents to your library.
Works referenced in this record:
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
journal, October 2015
- Borghaei, Hossein; Paz-Ares, Luis; Horn, Leora
- New England Journal of Medicine, Vol. 373, Issue 17
Structure-Based Druggability Assessment of the Mammalian Structural Proteome with Inclusion of Light Protein Flexibility
journal, July 2014
- Loving, Kathryn A.; Lin, Andy; Cheng, Alan C.
- PLoS Computational Biology, Vol. 10, Issue 7
Twenty years on: the impact of fragments on drug discovery
journal, July 2016
- Erlanson, Daniel A.; Fesik, Stephen W.; Hubbard, Roderick E.
- Nature Reviews Drug Discovery, Vol. 15, Issue 9
Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination
journal, May 2016
- Boutros, Celine; Tarhini, Ahmad; Routier, Emilie
- Nature Reviews Clinical Oncology, Vol. 13, Issue 8
MDM2 Small-Molecule Antagonist RG7112 Activates p53 Signaling and Regresses Human Tumors in Preclinical Cancer Models
journal, February 2013
- Tovar, C.; Graves, B.; Packman, K.
- Cancer Research, Vol. 73, Issue 8
B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
journal, December 1999
- Dong, Haidong; Zhu, Gefeng; Tamada, Koji
- Nature Medicine, Vol. 5, Issue 12
Cytokine release syndrome
journal, June 2018
- Shimabukuro-Vornhagen, Alexander; Gödel, Philipp; Subklewe, Marion
- Journal for ImmunoTherapy of Cancer, Vol. 6, Issue 1
Small Molecule Mimetics of an HIV-1 gp41 Fusion Intermediate as Vaccine Leads
journal, October 2010
- Caulfield, Michael J.; Dudkin, Vadim Y.; Ottinger, Elizabeth A.
- Journal of Biological Chemistry, Vol. 285, Issue 52
Isolating and engineering human antibodies using yeast surface display
journal, July 2006
- Chao, Ginger; Lau, Wai L.; Hackel, Benjamin J.
- Nature Protocols, Vol. 1, Issue 2
Chemical and physical instabilities in manufacturing and storage of therapeutic proteins
journal, December 2019
- Krause, Mary E.; Sahin, Erinc
- Current Opinion in Biotechnology, Vol. 60
An Experimentally Determined Evolutionary Model Dramatically Improves Phylogenetic Fit
journal, May 2014
- Bloom, Jesse D.
- Molecular Biology and Evolution, Vol. 31, Issue 8
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis
journal, July 2019
- Wang, Yucai; Zhou, Shouhao; Yang, Fang
- JAMA Oncology, Vol. 5, Issue 7
Ultra-large library docking for discovering new chemotypes
journal, February 2019
- Lyu, Jiankun; Wang, Sheng; Balius, Trent E.
- Nature, Vol. 566, Issue 7743
Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab
journal, June 2016
- Na, Zhenkun; Yeo, Siok Ping; Bharath, Sakshibeedu R.
- Cell Research, Vol. 27, Issue 1
Peptide-based and small synthetic molecule inhibitors on PD-1/PD-L1 pathway: A new choice for immunotherapy?
journal, January 2019
- Chen, Tingkai; Li, Qi; Liu, Zongliang
- European Journal of Medicinal Chemistry, Vol. 161
FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors
journal, February 2019
- Marcus, Leigh; Lemery, Steven J.; Keegan, Patricia
- Clinical Cancer Research, Vol. 25, Issue 13
Engaging neuroscience to advance translational research in brain barrier biology
journal, February 2011
- Neuwelt, Edward A.; Bauer, Björn; Fahlke, Christoph
- Nature Reviews Neuroscience, Vol. 12, Issue 3
Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
journal, October 2016
- Lee, Ju Yeon; Lee, Hyun Tae; Shin, Woori
- Nature Communications, Vol. 7, Issue 1
Cancer immunotherapy — immune checkpoint blockade and associated endocrinopathies
journal, January 2017
- Byun, David J.; Wolchok, Jedd D.; Rosenberg, Lynne M.
- Nature Reviews Endocrinology, Vol. 13, Issue 4
Coot model-building tools for molecular graphics
journal, November 2004
- Emsley, Paul; Cowtan, Kevin
- Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132
Pathways for Small Molecule Delivery to the Central Nervous System across the Blood-Brain Barrier
journal, January 2014
- Mikitsh, John L.; Chacko, Ann-Marie
- Perspectives in Medicinal Chemistry, Vol. 6
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
journal, January 2013
- Souers, Andrew J.; Leverson, Joel D.; Boghaert, Erwin R.
- Nature Medicine, Vol. 19, Issue 2
PHENIX: a comprehensive Python-based system for macromolecular structure solution
journal, January 2010
- Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor
- Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221
Pembrolizumab versus Ipilimumab in Advanced Melanoma
journal, June 2015
- Robert, Caroline; Schachter, Jacob; Long, Georgina V.
- New England Journal of Medicine, Vol. 372, Issue 26
Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1
journal, December 2015
- Zak, Krzysztof M.; Kitel, Radoslaw; Przetocka, Sara
- Structure, Vol. 23, Issue 12
Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2
journal, July 2008
- Lazar-Molnar, E.; Yan, Q.; Cao, E.
- Proceedings of the National Academy of Sciences, Vol. 105, Issue 30
Kinetic Rate Constant Prediction Supports the Conformational Selection Mechanism of Protein Binding
journal, January 2012
- Moal, Iain H.; Bates, Paul A.
- PLoS Computational Biology, Vol. 8, Issue 1
Systematic Targeting of Protein–Protein Interactions
journal, August 2016
- Modell, Ashley E.; Blosser, Sarah L.; Arora, Paramjit S.
- Trends in Pharmacological Sciences, Vol. 37, Issue 8
Structural Biology of the Immune Checkpoint Receptor PD-1 and Its Ligands PD-L1/PD-L2
journal, August 2017
- Zak, Krzysztof M.; Grudnik, Przemyslaw; Magiera, Katarzyna
- Structure, Vol. 25, Issue 8
Motif mediated protein-protein interactions as drug targets
journal, March 2016
- Corbi-Verge, Carles; Kim, Philip M.
- Cell Communication and Signaling, Vol. 14, Issue 1
Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
journal, September 2014
- Arkin, Michelle R.; Tang, Yinyan; Wells, James A.
- Chemistry & Biology, Vol. 21, Issue 9
Transient Pockets on Protein Surfaces Involved in Protein−Protein Interaction
journal, July 2007
- Eyrisch, Susanne; Helms, Volkhard
- Journal of Medicinal Chemistry, Vol. 50, Issue 15
Drug penetration in solid tumours
journal, August 2006
- Minchinton, Andrew I.; Tannock, Ian F.
- Nature Reviews Cancer, Vol. 6, Issue 8
Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging
journal, November 2015
- Maute, Roy L.; Gordon, Sydney R.; Mayer, Aaron T.
- Proceedings of the National Academy of Sciences, Vol. 112, Issue 47
Yeast surface display for screening combinatorial polypeptide libraries
journal, June 1997
- Boder, Eric T.; Wittrup, K. Dane
- Nature Biotechnology, Vol. 15, Issue 6
Deep mutational scanning: a new style of protein science
journal, July 2014
- Fowler, Douglas M.; Fields, Stanley
- Nature Methods, Vol. 11, Issue 8
HKL -3000: the integration of data reduction and structure solution – from diffraction images to an initial model in minutes
journal, July 2006
- Minor, Wladek; Cymborowski, Marcin; Otwinowski, Zbyszek
- Acta Crystallographica Section D Biological Crystallography, Vol. 62, Issue 8
Impact of high-throughput screening in biomedical research
journal, March 2011
- Macarron, Ricardo; Banks, Martyn N.; Bojanic, Dejan
- Nature Reviews Drug Discovery, Vol. 10, Issue 3
Conformational kinetics reveals affinities of protein conformational states
journal, July 2015
- Daniels, Kyle G.; Suo, Yang; Oas, Terrence G.
- Proceedings of the National Academy of Sciences, Vol. 112, Issue 30
Structure and Interactions of the Human Programmed Cell Death 1 Receptor
journal, February 2013
- Cheng, Xiaoxiao; Veverka, Vaclav; Radhakrishnan, Anand
- Journal of Biological Chemistry, Vol. 288, Issue 17
Structure-guided development of a high-affinity human Programmed Cell Death-1: Implications for tumor immunotherapy
journal, March 2017
- Lázár-Molnár, Eszter; Scandiuzzi, Lisa; Basu, Indranil
- EBioMedicine, Vol. 17
High-affinity PD-1 molecules deliver improved interaction with PD-L1 and PD-L2
journal, August 2018
- Li, Yanyan; Liang, Zhaoduan; Tian, Ye
- Cancer Science, Vol. 109, Issue 8
Discovery of small molecule cancer drugs: Successes, challenges and opportunities
journal, March 2012
- Hoelder, Swen; Clarke, Paul A.; Workman, Paul
- Molecular Oncology, Vol. 6, Issue 2
Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies
journal, January 2010
- Keizer, Ron J.; Huitema, Alwin D. R.; Schellens, Jan H. M.
- Clinical Pharmacokinetics, Vol. 49, Issue 8
Structure and Dynamics of PD-L1 and an Ultra-High-Affinity PD-1 Receptor Mutant
journal, October 2016
- Pascolutti, Roberta; Sun, Xianqiang; Kao, Joseph
- Structure, Vol. 24, Issue 10
High-resolution crystal structure of the therapeutic antibody pembrolizumab bound to the human PD-1
journal, October 2016
- Horita, Shoichiro; Nomura, Yayoi; Sato, Yumi
- Scientific Reports, Vol. 6, Issue 1
The history of monoclonal antibody development – Progress, remaining challenges and future innovations
journal, December 2014
- Liu, Justin K. H.
- Annals of Medicine and Surgery, Vol. 3, Issue 4
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
journal, June 2017
- Le, Dung T.; Durham, Jennifer N.; Smith, Kellie N.
- Science, Vol. 357, Issue 6349
Small molecules, big targets: drug discovery faces the protein–protein interaction challenge
journal, April 2016
- Scott, Duncan E.; Bayly, Andrew R.; Abell, Chris
- Nature Reviews Drug Discovery, Vol. 15, Issue 8
Roll: a new algorithm for the detection of protein pockets and cavities with a rolling probe sphere
journal, October 2009
- Yu, Jian; Zhou, Yong; Tanaka, Isao
- Bioinformatics, Vol. 26, Issue 1
The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors
journal, February 2008
- Lin, D. Y. -w.; Tanaka, Y.; Iwasaki, M.
- Proceedings of the National Academy of Sciences, Vol. 105, Issue 8
Small Molecules as PD-1/PD-L1 Pathway Modulators for Cancer Immunotherapy
journal, March 2019
- Jiao, Peifu; Geng, Qiaohong; Jin, Peng
- Current Pharmaceutical Design, Vol. 24, Issue 41
Pharmacokinetics and its role in small molecule drug discovery research
journal, January 2001
- Jang, Graham R.; Harris, Robert Z.; Lau, David T.
- Medicinal Research Reviews, Vol. 21, Issue 5
Structural and Functional Analysis of the Costimulatory Receptor Programmed Death-1
journal, March 2004
- Zhang, Xuewu; Schwartz, Jean-Claude D.; Guo, Xiaoling
- Immunity, Vol. 20, Issue 3
Hematopoietic stem cell mobilization following PD‐1 blockade: Cytokine release syndrome after transplantation managed with ascorbic acid
journal, June 2019
- Sindel, Ariel; Taylor, Trevor; Chesney, Alden
- European Journal of Haematology, Vol. 103, Issue 2
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
journal, March 2001
- Latchman, Yvette; Wood, Clive R.; Chernova, Tatyana
- Nature Immunology, Vol. 2, Issue 3